đđđI like
$WUXI BIO(02269)$ as it is China's largest biologics company and one of the top 5 in the world specialising in contract research, development and manufacturing in this sector.
WuXi Biologics is expanding with new facilities in Ireland, US, Chengdu and Singapore.
WuXi Biologics has strong financial momentum with revenue growing 16.7% YoY in 2025 and net profit up 17.9% YoY. It has also seen explosive growth in Bi and multi specific antibody revenue with revenue increasing by 120% YoY, representing 20% of total revenue.
I believe that WuXi Biologics has lots of exponential growth ahead in the future and would be a great stock to add to my watch list.
@Tiger_comments @Tiger_SG @TigerStars
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments